IJSTX | NAESX | IJSTX / NAESX | |
Total Expense Ratio | 1.28 | 0.17 | 753% |
Annual Report Gross Expense Ratio | 1.28 | 0.17 | 753% |
Fund Existence | 23 years | 65 years | - |
Gain YTD | -10.441 | 6.494 | -161% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 312M | 161B | 0% |
Annual Yield % from dividends | 0.05 | 1.20 | 4% |
Returns for 1 year | -7.36 | 13.62 | -54% |
Returns for 3 years | 4.76 | 39.23 | 12% |
Returns for 5 years | -3.15 | 66.60 | -5% |
Returns for 10 years | -19.10 | 132.36 | -14% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JAGLX | 70.01 | 0.54 | +0.78% |
Janus Henderson Global Life Sciences T | |||
AFICX | 90.43 | 0.49 | +0.54% |
American Funds Fundamental Invs C | |||
LICFX | 17.58 | 0.09 | +0.51% |
Lord Abbett International Equity F | |||
PGSLX | 11.51 | 0.05 | +0.44% |
Principal Global Listed Inf Inst | |||
MFWGX | 17.89 | 0.03 | +0.17% |
MFS Global Total Return R1 |